SCHEMBL8996346

SCHEMBL8996346

COc1cccc2c1C(=O)c1c(OC)cc(N)cc1C2=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.56
PIM1 P11309 1/20 0.56
ELANE P08246 7/20 0.55
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
ALDH1A1 P00352 5/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
MAPT P10636 4/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
APAF1 O14727 1/20 0.49
MITF O75030 1/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
CTSG P08311 1/20 0.47
FGB P02675 1/20 0.46
POLB P06746 1/20 0.46
THRB P10828 1/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8947495 0.85 EGFR (0.73) EGFRPIM1ELANEMEN1KMT2A
SCHEMBL9878296 0.83 ELANE (0.60) EGFRPIM1ELANEMEN1KMT2A
SCHEMBL10811289 0.82 EGFR (0.61) EGFRPIM1ELANEMEN1KMT2A
SCHEMBL15427118 0.82 TTR (0.55) ELANEMEN1KMT2AALDH1A1MAPT
SCHEMBL15413483 0.81 EGFR (0.56) EGFRPIM1ELANEMEN1KMT2A
SCHEMBL3417492 0.79 EGFR (0.76) EGFRPIM1ELANEMEN1KMT2A
SCHEMBL8996341 0.79 EGFR (0.54) EGFRPIM1ELANEMEN1KMT2A
SCHEMBL9878218 0.79 EGFR (0.54) EGFRPIM1ELANEMEN1KMT2A
SCHEMBL15427129 0.79 KCNA3 (0.47) ELANEMEN1KMT2AALDH1A1MAPT
SCHEMBL22336092 0.78 ALDH1A1 (0.54) EGFRPIM1ELANEMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872474-B1 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF UNIV GEORGIA STATE RES FOUND (US) 2022-01-19 EP disclosed
EP-2872474-B1 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF UNIV GEORGIA STATE RES FOUND (US) 2022-01-19 EP disclosed
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2020-01-28 US disclosed
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2020-01-28 US disclosed
CN-110526827-A Anthraquinone analogs and its preparation and application UNIV GEORGIA STATE RES FOUND 2019-12-03 CN disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
EP-2872474-A2 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF Georgia State University Research Foundation, Inc. (US) 2015-05-20 EP disclosed
CN-104507902-A Anthraquinone analogs and methods of making and using the same UNIV GEORGIA STATE RES FOUND 2015-04-08 CN disclosed
WO-2014011753-A2 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2014-01-16 WO disclosed
WO-2014011753-A2 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2014-01-16 WO disclosed
US-5480873-A ARTHRITIS LILLY INDUSTRIES LIMITED (GB) 1996-01-02 US disclosed
CN-1079732-A Medical compounds LILLY INDUSTRIES LTD (GB) 1993-12-22 CN disclosed
EP-0570091-A1 Anthraquinone derivatives, process for their preparation and their use as medicaments LILLY INDUSTRIES LIMITED (GB) 1993-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof PCNA, KRAS, RECQL EGFR 2701/4885PIM1 3546/4885ELANE 815/4885
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof PCNA, KRAS, RECQL EGFR 2701/4885PIM1 3546/4885ELANE 815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.